Modeling the effects of carriers on transmission dynamics of infectious diseases

Project Abstract

Infectious diseases are a significant public health concern, and understanding the dynamics of disease transmission is crucial for effective control and prevention strategies. One important factor that can influence the transmission dynamics of infectious diseases is the role of carriers - individuals who are infected with a pathogen but do not display symptoms of the disease. Carriers can play a key role in the spread of infectious diseases, as they may unknowingly transmit the pathogen to others. This research project aims to model the effects of carriers on the transmission dynamics of infectious diseases using mathematical modeling techniques. The study will focus on developing a compartmental model that incorporates carriers into the traditional Susceptible-Infectious-Recovered (SIR) framework. The model will take into account the different transmission rates between symptomatic and asymptomatic carriers, as well as the potential for carriers to transition between different states over time. By incorporating carriers into the transmission dynamics model, this research will provide valuable insights into how the presence of carriers can impact the spread of infectious diseases within a population. The model will allow for the exploration of various scenarios, such as the effects of different levels of carrier prevalence, the impact of carrier detection and isolation strategies, and the potential for carriers to drive outbreaks in certain settings. Furthermore, the study will investigate the implications of carriers on control measures such as vaccination, quarantine, and social distancing. Understanding how carriers influence the effectiveness of these interventions is critical for designing targeted and efficient disease control strategies. The model will be used to simulate different control strategies and assess their impact on disease transmission dynamics in the presence of carriers. Overall, this research project will advance our understanding of the role of carriers in infectious disease transmission and provide important insights for public health policymakers and practitioners. By developing a model that explicitly incorporates carriers, this study will contribute to the development of more accurate and realistic models for predicting and controlling the spread of infectious diseases in populations.

Project Overview

<p> </p><p><strong>1.0 INTRODUCTION</strong></p><p><strong>1.1 BACKGROUND OF STUDY</strong></p><p>For certain infectious diseases, there are individuals who are able to transmit their illness but do not exhibit any symptoms. These individuals are called “carriers” and they play an important role in the transmission of the disease. There are two types of carriers. <em>Genetic carriers </em>carry the illness on their recessive genes. They can only pass on their disease to their children and are not contagious. &nbsp; The focus of our study is on <em>infectious disease carriers</em>. These individuals are asymptomatic and are likely unaware of their conditions, and therefore are more likely to infect others. An infectious disease that produces long-term asymptotic carriers is the Typhoid fever caused by the bacteria Salmonella Typhi. Typhoid fever reached public notoriety at the beginning of the 20th century with the cases of “Mr. &nbsp; &nbsp; N the milker” in England and Typhoid Mary in the US. These individuals infected hundreds of people over the decades while they worked in the food production industry and private homes. Even today, Typhoid fever infects 21 million people and kills 200,000 worldwide every year. Asymptomatic carriers are believed to play an essential role in the evolution and global transmission of Typhi, and their presence greatly hinders the eradication of Typhoid fever using treatment and vaccination.</p><p>Another major infectious disease that causes long-term asymptomatic carriage is hepatitis B, a liver disease caused by the HBV virus of the Hepadnavirus family. Most people infected with HBV recover completely and develop a lifelong immunity to the virus. However, about 5-10% of adults will develop chronic HBV infection, and 15-25% of these will develop liver disease. Hepatitis B’s symptoms include jaundice, abdominal pain, nausea, fatigue and joint pain. About 30% of people with the disease do not show any of these symptoms. A major public-health challenge in the control of hepatitis B infection in many countries is the existence of a large pool of chronic carriers who are responsible for transmitting most of the new infections. Infections of other pathogens are also know to produce asymptomatic carriers. The Epstein-Barr Virus (EBV) of the herpes family is one of the most common viruses &nbsp; in humans. EBV infection commonly causes infectious mononucleosis, also known as glandular fever. Most people infected with EBV are asymptomatic, as it remains dormant in those who have had it for the rest of their lives in the cells of the &nbsp; &nbsp; &nbsp; throat and the immune system. Clostridium difficile is a bacterium that causes Clostridium difficile-associated diseases (CDAD). CDAD remains the most common cause of acute hospital-acquired diarrhea, responsible for more than 300,000 cases &nbsp; of diarrhea annually in acute-care facilities in the United States. Asymptomatic carriage rates of up to 30% have been reported in long-term care facilities. It is believed that carriers are responsible for transmission and large outbreaks of CDAD in Europe and North America.</p><p>Despite their public health significance, the effects of carriers on the transmission dynamics of the disease have not received adequate research attention in the mathematical modeling literature. One of the earlier attempts was Kempe, in which a general mathematical model that incorporates disease carriers was devel- oped and analyzed. Medley et al. used a mathematical model for hepatitis B with carriers to discuss the effects of HBV vaccination. Several other studies using large-scale computational models with carriers are specifically aimed at hepatitis B and other diseases</p><p><strong>1.2 STATEMENT OF PROBLEM</strong></p><p>What really instigated the study was the prevalence of highly infectious diseases in Nigeria. the growth of diseases in Nigeria and most African countries has increased overtime. It is evident that researchers have put in so much effort to come out with model on the effect of carriers on transmission dynamics of infectious diseases but some prove abortive.</p><p><strong>1.3 AIMS AND OBJECTIVES OF STUDY</strong></p><p>The main aim of the research work is to examine the modeling of the effect of carriers on transmission dynamics of infectious diseases. Other specific aims of the research work are:</p><p>1. To investigate the effects of carriers on the transmission dynamics</p><p>2. To determine the basic reproduction number and through numerical simulations</p><p>3. To investigate on the factors affecting the model</p><p>4. To proffer solution to the above model</p><p><strong>1.4 RESEARCH QUESTIONS</strong></p><p>The study came up with research questions so as to be able to ascertain the objectives of the study. The research questions are stated below as follows:</p><p>1. What are the effects of carriers on the transmission dynamics?</p><p>2. How to determine the basic reproduction number and through numerical simulations?</p><p>3. What are the factors affecting the model?</p><p><strong>1.5 SIGNIFICANCE OF STUDY</strong></p><p>The study on the modeling the effects of carriers on transmission dynamics of infectious diseases will be of immense benefit the ministry of health, hospitals, the state government and other researcher that wishes to carryout similar research as the study will be able to discuss the effects of carriers on the transmission dynamics and the factors affecting the model</p><p><strong>1.6 SCOPE OF STUDY</strong></p><p>The study on modeling the effects of carriers on transmission dynamics of infectious diseases is limited to the modeling of selected infectious diseases like typhoid; how they are transmitted and the model for their transmission.</p><p><strong>1.7 DEFINITION OF TERMS</strong></p><p><strong>DISEASES:</strong>&nbsp;is a particular abnormal condition, a disorder of a structure or function that affects part or all of an organism. The study of disease is called pathology which includes the causal study of etiology</p><p><strong>CARRIERS:</strong>&nbsp;individual harboring specific pathogenic organisms who, though often immune to the agent harbored, may transmit the disease to others</p><p><strong>INFECTIOUS:</strong>&nbsp;liable to be transmitted to people, organisms, etc. through the environment.</p> <br><p></p>